- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07806253
Relationships Between Muscle Activity, Soft Tissue Changes, and Movement Strategies in Individuals With Chronic Low Back Pain (E-LBP)
Study of the Relationships Between Muscle Activity, Soft Tissue Changes, and Movement Strategies in Individuals With Chronic Low Back Pain, in Order to Support Their Return to Sport and Physical Activity
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Léo Denouël, PhD Student
- Número de telefone: +33 (0) 681768024
- E-mail: leo.denouel@univ-rennes2.fr
Estude backup de contato
- Nome: Armel Crétual, Professor
- Número de telefone: +33 (0) 290091588
- E-mail: armel.cretual@univ-rennes2.fr
Locais de estudo
-
-
-
Rennes, França, 35000
- University of Rennes 2
-
Subinvestigador:
- Mathieu Ménard, PhD
-
Contato:
- Léo Denouël, PhD Student
- Número de telefone: +33 (0) 681768024
- E-mail: leo.denouel@univ-rennes2.fr
-
Contato:
- Armel Crétual, Professor
- Número de telefone: +33 (0) 290091588
- E-mail: armel.cretual@univ-rennes2.fr
-
Subinvestigador:
- Nolwenn Fougeron, PhD
-
Subinvestigador:
- Diane Haering, PhD
-
Subinvestigador:
- Armel Crétual, Professor
-
Subinvestigador:
- Olivier Roze, MD
-
Investigador principal:
- Emilie Leblong, MD
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Descrição
- Inclusion criteria for CNSLBP participants
Adult aged 18 to 65 years (inclusive) Have freely given written informed consent Present with pain located between the thoracolumbar junction and the inferior gluteal fold, with or without pain in one or both legs This pain must have been present for more than 12 weeks, on a daily or near-daily basis (at least 4 days out of 7) Participants must not be undergoing any treatment, or must have been on a stable analgesic treatment for at least 2 weeks prior to inclusion in the study Must not have performed, in the 72 hours preceding participation in the study, any unusual intense physical activity (e.g., carrying a heavy load (> 25 kg), sporting activity) likely to transiently alter muscle activity or the mechanical properties of the tissues studied
- Non-inclusion criteria for CNSLBP participants
Known contraindications or limitations to walking Cardiovascular risk factors (uncontrolled high blood pressure, poorly controlled diabetes or diabetes with complications, severe untreated dyslipidemia), or heart disease contraindicating physical activity Ongoing litigation following a workplace accident
Any form of specific low back pain, with an identified cause or secondary to an underlying condition, including in particular:
Pain related to a cancer diagnosis Spinal cord or cauda equina symptoms (pyramidal signs, coordination disorders, motor or sensory deficits, sphincter disorders, etc.) Pain following an infection (night sweats, fever, chills, intravenous drug abuse, immunodeficiency, recent surgery, urinary or skin infection, etc.) Recent or pathological fractures (road traffic accidents, history of osteoporosis, chronic corticosteroid use, advanced age, unexplained weight loss, fatigue, history of cancer, etc.) Inflammatory rheumatism (ankylosing spondylitis, rheumatoid arthritis, or other rheumatic diseases) Vascular problems (cold feet, diminished peripheral arterial pulse, etc.) Disabling radicular irradiation, at the investigator's discretion Participants must not have undergone an intensive rehabilitation program within the last 3 months, nor received physiotherapy, manual therapy, acupuncture, or any other type of manual medicine or bodywork treatment outside their usual care, within the 4 weeks preceding inclusion Severe, unstabilized psychiatric condition Person presenting with a pathology or orthopedic disorder affecting locomotion Recent spinal surgery (< 3 months before the inclusion visit) Systemic corticosteroid use, or corticosteroid injection at the lumbar spine, within the last 3 months Muscle relaxant use in the week preceding the experiment
- Inclusion criteria for asymptomatic participants
Adult aged 18 to 65 years (inclusive) Have freely given written informed consent Person presenting no form of low back pain and matching the age and male-to-female ratio characteristics of the CNSLBP group*
In accordance with Article L1121-8-1 of the French Public Health Code, participants must be affiliated to, or beneficiaries of, a social security scheme
To ensure correspondence in terms of age and sex ratio between the CNSLBP group and the healthy group, the frequency of age and gender categories among CNSLBP participants will be used to build, by matching, the group of healthy participants.
- Non-inclusion criteria for asymptomatic participants
Person reporting an ongoing chronic pain complaint or a history of significant chronic pain (≥ 4/10 for at least 6 months) (HAS, 2019) Person unable to perform the walking tasks studied without excessive discomfort or fatigue
- Non-inclusion criteria common to CNSLBP and asymptomatic participants
Known contraindications or limitations to walking Cardiovascular risk factors (uncontrolled high blood pressure, poorly controlled diabetes or diabetes with complications, severe untreated dyslipidemia), or heart disease contraindicating physical activity Severe, unstabilized psychiatric condition Person presenting with a pathology or orthopedic disorder affecting locomotion
(*) Persons referred to in Articles L. 1121-5 to L. 1121-8 and L. 1121-12 of the French Public Health Code:
Pregnant, parturient, or breastfeeding woman Person deprived of liberty by judicial or administrative decision Person hospitalized without consent and not subject to a legal protection measure, and person admitted to a healthcare or social institution for purposes other than research Person subject to an exclusion period for another study Adult subject to a legal protection measure (guardianship, conservatorship, or court protection), or adult unable to express consent and not subject to a protection measure
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Ciência básica
- Alocação: Não randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Non-specific Chronic Low Back Pain participants
Participants underwent a single assessment session including lumbar muscle ultrasound imaging, functional movement task analysis and a walking test.
No therapeutic intervention was administered.
|
After a warm-up period on the treadmill, the test involves walking, starting at a speed of 3 km/h and increasing the speed by 0.5 km/h every 2 minutes, up to a maximum of 7 km/h.
The speed of 7 km/h is a target speed and is not mandatory.
|
|
Experimental: Asymptomatic participants
Participants underwent a single assessment session including lumbar muscle ultrasound imaging, functional movement task analysis and a walking test.
No therapeutic intervention was administered.
|
After a warm-up period on the treadmill, the test involves walking, starting at a speed of 3 km/h and increasing the speed by 0.5 km/h every 2 minutes, up to a maximum of 7 km/h.
The speed of 7 km/h is a target speed and is not mandatory.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in muscle stiffness of the erector spinae and multifidus muscles between rest and after physical activity
Prazo: As the study consists of a single session, the time frame is between the pre-walking-test and post-walking-test assessments.
|
Change in muscle stiffness, measured by shear modulus using shear-wave elastography, of the erector spinae and multifidus muscles, between rest and after physical activity.
|
As the study consists of a single session, the time frame is between the pre-walking-test and post-walking-test assessments.
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Ultrasound morphological measurements
Prazo: Data were collected during the experimental session.
|
Measurement of the cross-sectional area and thickness-as determined by ultrasound-of the erector spinae and multifidus muscles at rest.
|
Data were collected during the experimental session.
|
|
Electromyographic activity
Prazo: Data were collected during the experimental session.
|
Lumbar muscle activations during three-dimensional lumbar movements and while walking
|
Data were collected during the experimental session.
|
|
Kinematics
Prazo: Data were collected during the experimental session.
|
The kinematics of the lumbopelvic-femoral complex (segmental velocity and acceleration, joint angles) during three-dimensional movements and while walking.
|
Data were collected during the experimental session.
|
|
General data
Prazo: Data were collected during the experimental session
|
Age, sex, height, weight, body mass index, and socioeconomic status are recorded.
|
Data were collected during the experimental session
|
|
Impact, effort, and sensations during the walking experience
Prazo: Data were collected during the experimental session
|
Intensity of pain experienced, measured using a numerical rating scale at rest and during activity. Perceived exertion during walking on a treadmill, measured using the Borg CR-10 scale. Heart rate recorded using a Garmin® HRM heart rate monitor. Time, distance, and speed achieved during the walking task |
Data were collected during the experimental session
|
|
Physical function
Prazo: Data from the questionnaire were collected during the experimental session, or shortly before (between 1 and 7 days beforehand)
|
Patients' physical function is assessed using the Oswestry Disability Index (ODI).
|
Data from the questionnaire were collected during the experimental session, or shortly before (between 1 and 7 days beforehand)
|
|
Pain intensity and location
Prazo: Data were collected during the experimental session
|
The intensity of pain experienced by participants on the day of the test, as measured by a numerical rating scale, and the location of the pain, as determined by the Pain Drawing test.
|
Data were collected during the experimental session
|
|
Daily impact of pain
Prazo: Data from the questionnaire were collected during the experimental session, or shortly before (between 1 and 7 days beforehand)
|
The daily impact of pain (daily activities, work, leisure, anxiety and depression, social life) is assessed using the Dallas Self-Report Questionnaire (DRAD).
|
Data from the questionnaire were collected during the experimental session, or shortly before (between 1 and 7 days beforehand)
|
|
Quality of life health-related
Prazo: Data from the questionnaire were collected during the experimental session, or shortly before (between 1 and 7 days beforehand)
|
Health-related quality of life is assessed using the SF-12 questionnaire (SF-12)
|
Data from the questionnaire were collected during the experimental session, or shortly before (between 1 and 7 days beforehand)
|
|
Physical activity and sedentary behavior
Prazo: Data from the questionnaire were collected during the experimental session, or shortly before (between 1 and 7 days beforehand)
|
Participants' physical activity and sedentary behavior are assessed using the French version of the Global Physical Activity Questionnaire (GPAQ).
|
Data from the questionnaire were collected during the experimental session, or shortly before (between 1 and 7 days beforehand)
|
|
Kinesiophobia
Prazo: Data from the questionnaire were collected during the experimental session, or shortly before (between 1 and 7 days beforehand)
|
Fear of physical injury related to movement is assessed using the Tampa Scale for Kinesiophobia (TSK).
|
Data from the questionnaire were collected during the experimental session, or shortly before (between 1 and 7 days beforehand)
|
|
Anxiety and depressive disorders
Prazo: Data from the questionnaire were collected during the experimental session, or shortly before (between 1 and 7 days beforehand)
|
Screening for anxiety and depressive disorders is performed using the Hospital Anxiety and Depression Scale (HAD).
|
Data from the questionnaire were collected during the experimental session, or shortly before (between 1 and 7 days beforehand)
|
|
Validity of ultrasound measurements
Prazo: Data were collected during the experimental session
|
The validity of ultrasound measurements is assessed by the intra-operator repeatability of ultrasound measurements.
|
Data were collected during the experimental session
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Emilie Leblong, MD, Fondation Saint Helier, 35043 Rennes, France
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 2026-A00042-49
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .